Thyroid Cancer clinical trials in Arkansas

5 actively recruiting thyroid cancer trials at 6 sites across Arkansas.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

This phase III trial compares the effect of cabozantinib versus combination dabrafenib and trametinib for the treatment of patients with differentiated thyroid cancer that does not respond to treatment (refractory) and which expresses a BR…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT06475989

Sites in Arkansas:

Mercy Hospital Fort Smith — Fort Smith, Arkansas
CARTI Cancer Center — Little Rock, Arkansas

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatment for adults with advanced solid tumors. The study will be conducted in two par…

Sponsor: Pfizer

NCT ID: NCT05538130

Sites in Arkansas:

Highlands Oncology Group, PA — Fayetteville, Arkansas
Highlands Oncology Group, PA — Rogers, Arkansas
Highlands Oncology Group, PA — Springdale, Arkansas

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other study medicines in people with solid tumors. This study is …

Sponsor: Pfizer

NCT ID: NCT05355701

Sites in Arkansas:

Highlands Oncology Group — Fayetteville, Arkansas
Highlands Oncology Group — Rogers, Arkansas
Highlands Oncology Group — Springdale, Arkansas

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in Arkansas:

Mercy Hospital Fort Smith — Fort Smith, Arkansas
CARTI Cancer Center — Little Rock, Arkansas

View on ClinicalTrials.gov →

NA Recruiting Network

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Sponsor: Eastern Cooperative Oncology Group

NCT ID: NCT05108298

Sites in Arkansas:

Mercy Hospital Fort Smith — Fort Smith, Arkansas
CHI Saint Vincent Cancer Center Hot Springs — Hot Springs, Arkansas
CARTI Cancer Center — Little Rock, Arkansas

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20